VATS Versus Thoracotomy for Pulmonary Hydatid Disease (VATS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04412512|
Recruitment Status : Completed
First Posted : June 2, 2020
Last Update Posted : June 2, 2020
The aim of this study is to evaluate the efficacy and safety of minimally invasive surgery and compare the outcomes with patients undergoing thoracotomy in treatment of Pulmonary Hydatid Cyst.
Disease : pulmonary hydatid cyst.
- Group 1 : VATS approach.
- Group 2 : thoracotomy approach.
|Condition or disease||Intervention/treatment||Phase|
|Pulmonary Hydatid Cyst||Procedure: VATS approach Procedure: Thoracotomy approach||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||134 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||study the effect of a treatment and evaluate outcome postoperative|
|Official Title:||VATS Versus Thoracotomy for Pulmonary Hydatid Disease|
|Actual Study Start Date :||January 2016|
|Actual Primary Completion Date :||December 2019|
|Actual Study Completion Date :||April 2020|
Experimental: VATS approach
patients treated by VATS technique.
Procedure: VATS approach
video-assisted thoracic surgery approach
Active Comparator: Thoracotomy approach
patients treated by Thoracotomy technique
Procedure: Thoracotomy approach
- Postoperative complications [ Time Frame: 30 days ]evaluate the complication at 30 days
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04412512
|Hassan II University|
|Casablanca, Morocco, 20000|
|Principal Investigator:||sara WAGUAF||Hassan II University|